Hematology Oncology Services of Arkansas — Little Rock, Arkansas

Hematology Oncology Services of Arkansas is a clinical research site located in Little Rock, Arkansas, United States 72205.

Crixeo Clinical Trials Trust Score: 19/100 (FAILING). This profile has not yet been claimed by the site owner.

Hematology Oncology Services of Arkansas has participated in 12 clinical trials.

Therapeutic areas: Ovarian Neoplasms, First or Second Line HER2-negative Breast Cancer, Metastatic Disease Without Bone Metastasis.

Sponsors: Telik, Novartis Pharmaceuticals, Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Little Rock

Browse all research sites in Arkansas · View every site in Little Rock

Sponsor Feasibility Report

Trust Score: 19/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hematology Oncology Services of Arkansas?

Hematology Oncology Services of Arkansas has a Crixeo Trust Score of 19/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hematology Oncology Services of Arkansas conducted?

Hematology Oncology Services of Arkansas has 12 clinical trials on record. Their work covers Ovarian Neoplasms, First or Second Line HER2-negative Breast Cancer, Metastatic Disease Without Bone Metastasis.

Is Hematology Oncology Services of Arkansas accredited by Crixeo Clinical Trials?

Hematology Oncology Services of Arkansas has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Hematology Oncology Services of Arkansas?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.